2-1. Osteoporose. Dr. P. Van Wettere Radiologie en medische beeldvorming
|
|
- Barnard Conrad Bruce
- 7 years ago
- Views:
Transcription
1 2-1 Osteoporose Dr. P. Van Wettere Radiologie en medische beeldvorming
2 2-2 Osteoporose Definitie Incidentie, mortaliteit, morbiditeit, kost Diagnose Radiologie Botdensitometrie FRAX
3 FractureCascade History Asymptomatic in the prefracture phase 2-3
4 Prevent Vertebral Fracture Cascade 2-4 B/L 10YR 20YR
5 2-5 Definition of Osteoporosis A disease characterized by low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. World Health Organization (WHO), 1994 Normal bone Osteoporosis
6 Pathogenesis of Osteoporotic Fracture 2-6 Low peak bone mass Postmenopausal Bone loss Age related bone loss LOW BONE MASS Other risk factors Non skeletal factors (propensity to fall) FRACTURE = Fall + Low BMD Poor bone quality (architecture) LOW BMD = PBM or Loss Adapted from Melton LJ & Riggs BL. Osteoporosis: Etiology, Diagnosis and Management Raven Press, 1988, pp
7 2-7 Determinants of Peak Bone Mass Genetics Nutrition PEAK BONE MASS years of age Hormones Lifestyle
8 2-8 OSTEOPOROSIS: THE SIZE OF THE PROBLEM
9 2-9 Osteoporosis is a Prevalent Disease Affects 200 million women worldwide 1-1/3 of women aged 60 to 70-2/3 of women aged 80 or older Approximately 20-25% of women over the age of 50 have one or more vertebral fractures 2 - United States: 25% 3 - Australia: 20% 4 - Western Europe: 19% 5 - Scandinavia: 26% 5 - Denmark: 21% 6 1. International Osteoporosis Foundation 4. Jones G et al., Osteoporos Int 1996, 6: Melton LJ 3rd et al., Spine 1997, 22:2S 5. O'Neill et al., J Bone Miner Res 1996, 11: Ettinger B et al., J Bone Miner Res 1992,7: Jensen GF et al., Clin Orthop 1982,166:75
10 2-10 Vertebral Fractures Most common fracture type Often silent Insidious, progressive nature Associated with deformity, height loss, back pain impaired breathing increased morbidity and mortality Predict future spine and hip fractures
11 Incidence Rates for Vertebral, Wrist & Hip Fractures in Women after Age Annual incidence per 1000 women Vertebrae Hip Wrist Age (Years) Wasnich RD, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edition, 1999
12 2-12 Osteoporotic Fracture Incidence 4,000 Women Men Incidence / 100,000 Person-Years 3,000 2,000 1,000 Vertebrae Hip Vertebrae Hip Forearm Forearm Age (Years) Cooper C. et al, Trends Endocrinol Metab 1992; 3:224
13 Incidence United States) of Osteoporotic Fractures ( Only 30% of morphometric vertebral fractures are clinically apparent 2-13 Annual Incidence 750, , , ,000 Clinically apparent 300, , , Vertebral (Morphometric) Hip Wrist Fracture Type Other
14 Osteoporotic Fractures in Women: Comparison with Other Diseases 2-14 Annual incidence x * hip forearm other sites vertebral * annual incidence all ages annual estimate women 29+ annual estimate women new cases, all ages Osteoporotic Fractures Heart Attack Stroke Breast Cancer Riggs BL, Melton LJ. Bone 1995 Heart and Stroke Facts, 1996, American Heart Association Cancer Facts & Figures, 1996, American Cancer Society
15 Projected Burden of Osteoporotic Hip Fractures Worldwide 2-15 Estimated number hip fractures (x1000) Total no. hip fractures 1990 = 1.66 million 2050 = 6.26 million 0 North America Europe Latin America Asia Adapted from Cooper C., Melton LJ, Osteoporos Int 1992, 2:285
16 Projected Number of Osteoporotic Hip Fractures Worldwide Projected to reach million in Asia by Total number of hip fractures: 1950 = 1.66 million 2050 = 6.26 million Estimated number of hip fractures: (1000s) Adapted from C. Cooper et al, Osteoporos Int. 1992; 2:285-9
17 OSTEOPOROSIS: MORTALITY & MORBIDITY 2-17
18 Cumulative Survival Probability WOMEN 1.0 MEN Survival probability Survival probability Age Age Center JR et al., Lancet 1999, 353:878 Dubbo Population Vertebral/Major Fractures Proximal Femur Fractures
19 Mortality Rates by Number of Prevalent Vertebral Fractures Mortality (per 1000 person-years) Number of Vertebral Fractures Kado DM et al., Arch Intern Med 1999,159:1215 P for trend < 0.001
20 Relative Risk of Death Following Clinical Fractures 2-20 Fracture Intervention Trial (FIT)* Any Symptomatic Non-spine Hip Spine Forearm Other Age-Adjusted Relative Risk (95% CI) *6459 postmenopau sal women ages years followed for an average of 3.8 years Cauley JA et al., Osteoporos Int 2000, 11:556
21 Clinical Consequences 2-21 Kyphosis Loss of height Bulging abdomen Acute and chronic pain Breathing difficulties, reflux and other GI symptoms Depression REDUCED QUALITY OF LIFE
22 2-22 Vertebral Fractures Substantially Increase the Risk of New Fragility Fractures Women with vertebral fractures have a 5-fold increased risk of a new vertebral fracture and a 2-fold increased risk of hip fracture Black et al., J Bone Miner Res 1999 Melton et al, Osteoporos Int 1999 One woman in five will suffer from another vertebral fracture within a year Lindsay et al., JAMA, 2001
23 2-23 High Rate of Repeat Fractures % of Patients Fracturing Again within 1 Year Multiple 20% of women with new vert fx will re-fracture within one year Number of Spine Fractures at Start of Year Lindsay, 2000
24 Effect of Prior Vertebral Fracture on Risk of Subsequent Vertebral Fracture 2-24 Incidence of New Vertebral Fracture (%) RR=5.1 (3.1, 8.4) RR=2.6 (1.4, 4.9) RR=7.3 (4.4, 12.3) First Year of Study 2725 postmenopausal women randomised to placebo No. of Vertebral Fractures at Baseline Adapted from Lindsay R et al., JAMA 2001, 285:320
25 2-25 Vertebral Fractures in Summary Are the most common osteoporotic fractures Are associated with excess mortality Are associated with significant morbidity, even if they do not come to clinical attention Increase the risk of subsequent vertebral fracture(s) by 5 fold and of other fragility fractures (including hip) by 2 fold
26 2-26 Hip Fracture Impact on Life Quality 61 % of hip fractures occur at home 100 % hospitalized 82 % referred to rehabilitation clinic One year after hospitalization: 65 % live at home 17 % deceased 18 % need nursing Schürch M. et al, J. Bone Miner Res 1996; 12:
27 COST OF OSTEOPOROSIS 2-27
28 2-28 Some Costs of Osteoporosis in Europe In Europe the total direct costs of osteoporotic fractures are over 31 billion and are expected to increase to more that 76 billion in Kanis JA & Johnell O. - Osteoporos Int 2005 (in press) In France osteoporotic hip fractures are estimated to cost about 1 billion every year* In Spain the total direct hospital cost of osteoporotic fractures in 1995 was approximately 222 million* In England & Wales the total direct hospital cost of osteoporotic fractures in 1999 was approximately 847 million* *Osteoporosis in the European Community: A Call to Action. IOF Nov, 2001
29 Osteoporosis Results in More Disability & Direct Hospital Cost Than Many Other Diseases % of vertebral fractures are hospitalised and 2% require long-term nursing care Ross et al., Am Journal of Medicine 1997, 103(2A):30S 42S Annual cost of acute hospitalisation in Switzerland in 1992: 600 million Swiss francs (US$350 million) Lippuner et al., Osteoporosis Int 1997, 7: Number of bed days (men & women) 891,000 for COPD 701,000 for osteoporosis 533,000 for stroke 328,000 for myocardial infarction 201,000 for breast cancer Osteoporosis # 1 when looking at women only
30 2-30 UNDER-DIAGNOSIS OF VERTEBRAL FRACTURES: WHAT IS THE SIZE OF THE PROBLEM? Look for it!!
31 2-31 Unrecognized Vertebral Fractures On X-Ray women age 60 and older, hospitalized for various reasons Chest x-rays reviewed for fracture Number of Subjects % 40 23% 17% 20 7% 0 Fracture Present Mentioned in Report Mentioned in Summary Osteoporosis in Med Record Treatment for Osteoporosis Gehlbach SH et al, Osteoporos Int 2000;11:
32 2-32 High Prevalence of Vertebral Deformities 80 Prevalence of Deformities* (%) Melton, Age (yrs) 25% of women over age 50 have Vertebral Deformities
33 2-33 A Large Prospective Study Demonstrates Under- Diagnosis of Vertebral Fractures is a Worldwide Problem Vertebral fractures were markedly under-diagnosed in radiology reports in a multicenter, multinational study population of osteoporotic women (n=2451) in which 789 (32%) women had 1 vertebral fracture at baseline. Adjudicated discrepancies (n=350) between local and central readings due to undetected vertebral fracture (68%) or equivocal terminology in the local radiology report (32%) yielded a false-negative rate of 34%. Under-diagnosis of vertebral fractures was observed in all geographic regions (false-negative rates: North America 45.2%, Latin America 46.5%, Europe/South Africa/Australia 29.5%). The false-positive rate was 5% globally. Under-diagnosis of vertebral fracture is a worldwide problem attributable in part to a lack of radiographic detection or use of ambiguous terminology in the radiology report, or both. Delmas et al., J Bone Miner Res 2005, in press.
34 Background 2-34 Worldwide, a substantial percentage of vertebral fractures are not diagnosed by radiologists or clinicians It is likely that this contributes to unnecessary pain and suffering and to the under treatment of osteoporosis Identification of patients with a vertebral fracture is important because the presence of prevalent fracture greatly increases the risk of future fracture Recent widespread approval of effective treatments for patients with osteoporotic vertebral fractures
35 2-35 Problem: Vertebral Fracture Assessment by Radiologists Vertebral Fractures are: Not being identified Not being reported Not being acted upon
36 2-36 Are Physicians Treating Osteoporosis after Hip Fracture Center I II III IV n DXA 12% 12% 13% 24% Ca-Suppl. 27% 1% 3% 25% Estrogens 10% 6% 0% 14% Alendronate 8% 2% 4% 10% Calcitonin 11% 0% 0% 14% Raloxifene 0.1% 0% 1% 6% Total Treatment 29.1% 8% 5% 37% Harrington J. et al, Arthritis & Rheum. 2002; 47:651
37 2-37 Treatment of Osteoporosis Are Physicians Missing an Opportunity? 1162 women with a distal radial fracture, > 55yrs (60% < 74yrs) 2.8% had a bone-density scan (in 80% Osteoporosis found) 22.9% were treated with at least one medication (estrogen, bisphosphonates, calcitonin) 76% received neither a bone-density scan nor medical treatment of osteoporosis Freedman K. et al, J. Bone and Joint Surg 2000; 82-A:
38 2-38 When to Consider X-Ray Exam Clinical suspicion of vertebral fracture Pain Kyphosis Loss of height
Osteoporosis and Vertebral Compression (Spinal) Fractures Fact Sheet
Osteoporosis and Vertebral Compression (Spinal) Fractures Fact Sheet About Osteoporosis Osteoporosis is estimated to affect 200 million women worldwide. 1 Worldwide, osteoporosis causes more than nine
More informationFast Facts on Osteoporosis
Fast Facts on Osteoporosis Definition Prevalence Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an
More informationOsteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community
Osteoporosis Assessment Using DXA and Instant Vertebral Assessment Working Together For A Healthier Community Osteoporosis The Silent Thief The Facts About Osteoporosis 1 in 2 women will develop osteoporosis
More informationOsteoporosis/Bone Health in Adults as a National Public Health Priority
Position Statement Osteoporosis/Bone Health in Adults as a National Public Health Priority This Position Statement was developed as an educational tool based on the opinion of the authors. It is not a
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationPRACTICAL DENSITOMETRY
PRACTICAL DENSITOMETRY The Challenge of Osteoporosis Osteoporosis is a silent disease that develops over decades Goal: identify patients with osteoporosis before fractures occur Means: measure bone density
More informationOsteoporosis has been identified by the US Surgeon General
New Guidelines for the Prevention and Treatment of Osteoporosis E. Michael Lewiecki, MD, and Nelson B. Watts, MD Abstract: The World Health Organization Fracture Risk Assessment Tool (FRAX ) and the National
More information16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS
16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS Goal Reduce the impact of several major musculoskeletal conditions by reducing the occurrence, impairment, functional limitations, and limitation
More informationClinical Policy Guideline
Clinical Policy Guideline Policy Title: Bone Density Testing Policy No: B0215A.00 Effective Date: 01/01/15 Date Reviewed: 03/25/15 I. DEFINITION/BACKGROUND Bone density testing is used to estimate the
More informationRecent Topics in Treatment of Osteoporosis
Review Article Recent Topics in Treatment of Osteoporosis JMAJ 49(9 10): 309 314, 2006 Satoshi Soen* 1 Abstract It has come to light that osteoporosis-related fractures are more critical than previously
More informationFRAX Identifying people at high risk of fracture
FRAX Identifying people at high risk of fracture WHO Fracture Risk Assessment Tool, a new clinical tool for informed treatment decisions Authored by Dr. Eugene McCloskey International Osteoporosis Foundation
More informationBone Basics National Osteoporosis Foundation 2013
When you have osteoporosis, your bones become weak and are more likely to break (fracture). You can have osteoporosis without any symptoms. Because it can be prevented and treated, an early diagnosis is
More informationEpidemiology, costs and burden of osteoporosis in Mexico
DOI 10.1007/s11657-010-0042-8 REVIEW Epidemiology, costs and burden of osteoporosis in Mexico Patricia Clark Fernando Carlos José Luis Vázquez Martínez Received: 16 April 2010 /Accepted: 28 June 2010 #
More informationFalls and Fracture Risk assessment and management
Falls and Fracture Risk assessment and management Disclosures: Although various guidelines and studies were reviewed, this represents my own personal bias and conclusions. What do we know? 1) Fractures
More informationOsteoporosis Update. Laura E. Ryan, MD
Osteoporosis Update Laura E. Ryan, MD Assistant Director for Special Programs Center for Women s Health Clinical Assistant Professor of Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio
More informationPress Information. Vitamin D deficiency
DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com Vitamin D is one of the essential nutrients for human health. Unlike other types of vitamins
More informationOrthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now
Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Laura L. Tosi, MD Director, Bone Health Program Children s National Medical Center Washington, DC Epidemiology 87-93% of children born
More informationOsteoporosis: The patient s perspective. Claire Severgnini Chief Executive
Osteoporosis: The patient s perspective Claire Severgnini Chief Executive 1 Osteoporosis A long-term condition, mainly affecting people in later life Bones are fragile and more likely to fracture easily
More informationBone Densitometry. What is a Bone Density Scan (DXA)?
Scan for mobile link. Bone Densitometry Bone densitometry, also called dual-energy x-ray absorptiometry or DEXA, uses a very small dose of ionizing radiation to produce pictures of the inside of the body
More informationHow To Choose A Biologic Drug
North Carolina Rheumatology Association Position Statements I. Biologic Agents A. Appropriate delivery, handling, storage and administration of biologic agents B. Indications for biologic agents II. III.
More informationCompliance with drug therapies for the treatment and prevention of osteoporosis
Maturitas 48 (2004) 271 287 Compliance with drug therapies for the treatment and prevention of osteoporosis Jeffrey S. McCombs a,, Patrick Thiebaud b, Connie McLaughlin-Miley c, Jinhai Shi c a Department
More informationDrug treatment pathway for Osteoporosis in Postmenopausal Women
Drug treatment pathway for Osteoporosis in Postmenopausal Women Version 1.0 Ratified by: East Sussex HEMC Date ratified: 26.01.2011 Job title of originator/author Gillian Ells, East Sussex HEMC Pharmacist
More informationPROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES
PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES Patients newly diagnosed as osteopenic or osteoporotic on a radiology report or patients receiving abnormal lab values on the following lab tests
More informationX-Plain Vertebral Compression Fractures Reference Summary
X-Plain Vertebral Compression Fractures Reference Summary Introduction Back pain caused by a vertebral compression fracture, or VCF, is a common condition that affects thousands of people every year. A
More informationThe Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention
The Women s Health Initiative: The Role of Hormonal Therapy in Disease Prevention Robert B. Wallace, MD, MSc Departments of Epidemiology and Internal Medicine University of Iowa College of Public Health
More informationWhat You Need to Know for Better Bone Health
What You Need to Know for Better Bone Health A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be Bone health has a major effect on your quality of life
More informationMeasure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization
Client HMSA: PQSR 2009 Measure Title X RAY PRIOR TO MRI OR CAT SCAN IN THE EVAULATION OF LOWER BACK PAIN Disease State Back pain Indicator Classification Utilization Strength of Recommendation Organizations
More informationIf you were diagnosed with cancer today, what would your chances of survival be?
Q.1 If you were diagnosed with cancer today, what would your chances of survival be? Ongoing medical research from the last two decades has seen the cancer survival rate increase by more than 40%. However
More informationCMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
CANADIAN M EDICAL A SSOCIATION J OURNAL J OURNAL DE L ASSOCIATION MÉDICALE CANADIENNE CMAJ JAMC 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CMAJ 2002;167(10
More informationService delivery interventions
Service delivery interventions S A S H A S H E P P E R D D E P A R T M E N T O F P U B L I C H E A L T H, U N I V E R S I T Y O F O X F O R D CO- C O O R D I N A T I N G E D I T O R C O C H R A N E E P
More informationOsteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone.
Osteoporosis The bones in our skeleton are made of a thick outer shell and a strong inner mesh filled with collagen (protein), calcium salts and other minerals. Osteoporosis The inside looks like honeycomb,
More informationSPINAL FRACTURES OUR TREATMENT GUIDE
SPINAL FRACTURES OUR TREATMENT GUIDE 7 Cervical Spinal fractures are common around the world and can have a major impact on your quality of life. If not treated soon enough, they can even make carrying
More informationNATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal
More informationClinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men
Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men February 2010 Approved by NHMRC on 5 February 2010 The Royal Australian College of General Practitioners,
More informationA Treatment Algorithm for Indian Patients of Osteoporosis
Indian Medical Gazette FEBRUARY 2012 67 Symposia Update A Treatment Algorithm for Indian Patients of Osteoporosis Shailendra Mohan Lakhotia, Senior Consultant Orthopedic Surgeon, Kolkata 700 045. Prashant
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE This is an updated guideline It incorporates the latest NICE guidance There are strong recommendations for calcium + vitamin D
More informationOsteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco steve.harris@ucsf.edu Disclosure
More informationHormone therapy and breast cancer: conflicting evidence. Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group
Hormone therapy and breast cancer: conflicting evidence Cindy Farquhar Cochrane Menstrual Disorders and Subfertility Group The world of hormone therapy in the 1990 s Throughout the 1970s, 1980s and 1990s
More informationDEFINITION OF OSTEOPOROSIS
CHAPTER 27 OSTEOPOROSIS AND OSTEOMALACIA DEFINITION OF OSTEOPOROSIS THE EPIDEMIOLOGY AND CONSEQUENCES OF OSTEOPOROSIS REVIEW OF BONE REMODELING BONE LOSS PATHOGENESIS OF OSTEOPOROSIS DIAGNOSIS OF OSTEOPOROSIS
More informationHEALTH CARE COSTS 11
2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about
More informationBONE MINERAL DENSITOMETRY REPORTING
CAR TECHNICAL STANDARDS FOR BONE MINERAL DENSITOMETRY REPORTING APPROVED: JANUARY 25, 2013 KERRY SIMINOSKI, MD, FRCPC; MARGARET O'KEEFFE, MD, FRCPC; JACQUES P. BROWN, MD, FRCPC; STEVEN BURRELL, MD, FRCPC;
More informationTreatment of osteoporosis in fragility fractures
Orthogeriatrics Clinical Summary Document Treatment of osteoporosis in fragility fractures Fragility fractures are extremely prevalent in older adults with a staggering cost of treatment. As the population
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS
European Medicines Agency London, 16 November 2006 Doc. Ref. CPMP/EWP/552/95 Rev. 2 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT
More informationBarriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons
334 Original Article Barriers to Osteoporosis Identification and Treatment Among Primary Care Physicians and Orthopedic Surgeons CHRISTINE SIMONELLI, MD; KATHLEEN KILLEEN, MOT; SUSAN MEHLE, BS; AND LEAH
More informationStickler Syndrome and Arthritis
Stickler Syndrome and Arthritis Arthritis Foundation Pacific Region, Nevada Office Presented by: Crystal Schulz, MPH Community Development Manager Arthritis Foundation Improving lives through leadership
More informationOsteoporosis International. Original Article. The Cost of Treating Osteoporotic Fractures in the United Kingdom Female Population
Osteoporos Int (1998) 8:611 617 ß 1998 European Foundation for Osteoporosis and the National Osteoporosis Foundation Osteoporosis International Original Article The Cost of Treating Osteoporotic Fractures
More informationHealth Benchmarks Program Clinical Quality Indicator Specification 2013
Health Benchmarks Program Clinical Quality Indicator Specification 2013 Measure Title USE OF IMAGING STUDIES FOR LOW BACK PAIN Disease State Musculoskeletal Indicator Classification Utilization Strength
More informationNovember 2014. 3. This submission focuses on the following areas:
November 2014 Arthritis Research UK response: Centre for Policy on Ageing and Local Government Association call for evidence on local government s response to an ageing society 1. Arthritis Research UK
More informationLoss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women
Eur J Epidemiol (2009) 24:707 712 DOI 10.1007/s10654-009-9381-4 LOCOMOTOR DISEASES Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal
More informationBone Mineral Density Studies
Bone Mineral Density Studies Policy Number: 6.01.01 Last Review: 5/2015 Origination: 10/1988 Next Review: 5/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for bone
More informationClinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report
Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report Authors: Alexandra Papaioannou MD MSc 1, Suzanne Morin MD MSc 2, Angela M. Cheung
More informationThe Effect of Alendronate on the Age-Specific Incidence of Symptomatic Osteoporotic. Fractures. Maastricht 6
Revised Manuscript The Effect of Alendronate on the Age-Specific Incidence of Symptomatic Osteoporotic Fractures Marc C. Hochberg 1, Desmond E. Thompson 2, Dennis M. Black 3, Sara A. Quandt 4, Jane Cauley
More informationBULLETIN. Slovak Republic Ministry of Health
BULLETIN Slovak Republic Ministry of Health Part 51-53 November 13, 2009 No. 57 CONTENTS: 52. Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoidinduced Osteoporosis 52. Slovak
More informationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
DOI 10.1007/s00198-012-2074-y POSITION PAPER European guidance for the diagnosis and management of osteoporosis in postmenopausal women J. A. Kanis & E. V. McCloskey & H. Johansson & C. Cooper & R. Rizzoli
More informationOsteoarthritis and osteoporosis
Osteoarthritis and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationEpidemiology, Staging and Treatment of Lung Cancer. Mark A. Socinski, MD
Epidemiology, Staging and Treatment of Lung Cancer Mark A. Socinski, MD Associate Professor of Medicine Multidisciplinary Thoracic Oncology Program Lineberger Comprehensive Cancer Center University of
More informationRole of Dual-Energy X-Ray Absorptiometry in the Diagnosis and Treatment of Osteoporosis
Journal of Clinical Densitometry, vol. 10, no. 1, 102e110, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry 1094-6950/07/10:102e110/$32.00 DOI: 10.1016/j.jocd.2006.11.001 Review
More informationPerformance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women
Int J Endocrinol Metab 2007; 1: 26-32 Performance of Osteoporosis Risk Assessment Tools in Iranian Postmenopausal Women ORIGINAL ARTICLE Dabbaghmanesh MH a, Sabet R b, Aria A a, R Omrani GR a aendocrine
More informationCare pathways for vertebral compression fractures
Care pathways for vertebral compression fractures SYDNEY MEDICAL SCHOOL Associate Professor Manuela L Ferreira, PhD Sydney Medical Foundation Fellow Institute of Bone and Joint Research and The George
More informationClient Sex Facility Birth Date Height Weight Measured Sample Client Male (not specified) 00/00/0000 72.0 in. 180.0 lbs. 02/20/2016
SUMMARY RESULTS This table provides an overview of your total body composition, broken down into total body fat %, total mass, fat tissue, lean tissue, and bone mineral content. These metrics establish
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationOSTEOPOROSIS OROR OR. Towards a Fracture-Free Future
OSTEOPOROSIS OROR OR Towards a Fracture-Free Future March, 2011 Patients with fragility fractures are at the highest risk of developing new fractures. Interventions can reduce that risk! 1 Executive Summary
More informationCost Effectiveness Estimate of Bazedoxifene
Article ID: WMC002547 2046-1690 Cost Effectiveness Estimate of Bazedoxifene Corresponding Author: Dr. Ana A Iglesias, pharmacist, Pharmacy Department - Hospital of Manacor - Spain Submitting Author: Dr.
More informationOSTEOPOROSIS REHABILITATION PROGRAM
OSTEOPOROSIS REHABILITATION PROGRAM Tricia Orme, R.N. BSc(N) Mary Pack Arthritis Program Victoria i Arthritis i Centre Objectives Participants will gain an understanding of what Osteoporosis is and how
More informationUs TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy
Us TOO University Presents: Estrogen Deficiency Side Effects Due to Androgen Deprivation Therapy Today s speaker is Samir Taneja, MD Program moderator is Pam Barrett, Us TOO International Made possible
More informationType 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
More information(212) 733-2324 mackay.jimeson@pfizer.com
For immediate release: July 9, 2012 Media Contacts: MacKay Jimeson (212) 733-2324 mackay.jimeson@pfizer.com Pfizer Recognizes 10 th Anniversary Of The Women s Health Initiative: A Modern Day Perspective
More informationASSESSMENT OF OSTEOPOROSIS AT THE PRIMARY HEALTH CARE LEVEL
WHO Scientific Group Technical Report ASSESSMENT OF OSTEOPOROSIS AT THE PRIMARY HEALTH CARE LEVEL Reference Kanis JA on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis
More informationOsteoporosis. Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist. Rheumatology and Arthritis Seminar Tuesday 5 th February 2013
Osteoporosis Dr Gordon MacDonald BSc MB BChir MRCP Consultant Rheumatologist Rheumatology and Arthritis Seminar Tuesday 5 th February 2013 Plan What is osteoporosis? Consequences of osteoporosis Risk factors
More informationHormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions
Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions IMPORTANCE OF HORMONE BALANCE Importance of Hormone Balance Help you live a long, healthy life Help you
More informationDoes chronic lymphocytic leukemia increase the risk of osteoporosis?
Does chronic lymphocytic leukemia increase the risk of osteoporosis? Amrita Desai, MD Internal Medicine Residency Program Adam Olszewski, MD Department of Hematology and Oncology Memorial Hospital of Rhode
More informationOST and BMD Risk Assessment in Morocco
DOI 10.1007/s10067-007-0611-4 ORIGINAL ARTICLE Performance of the osteoporosis risk assessment tool in Moroccan men Mirieme Ghazi & Aziza Mounach & Abderrazak Nouijai & Imad Ghozlani & Loubna Bennani &
More informationBISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW (BRONJ) BISPHOSPHONATES AND WHAT HAPPENS TO BONE VINCENT E. DIFABIO, DDS, MS MEMBER OF THE COMMITTEE ON HEALTHCARE AND ADVOCACY FROM THE AMERICAN ASSOCIATION
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationMeasure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care
Measure #41: Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY
More informationGUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. CP57 Version: V3
GUIDELINES FOR ASSESSMENT OF SPINAL STABILITY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: CP57 Version: V3 Dr V. Misra Accountable Committee: Acute Oncology Group Network
More informationOsteoporosis in elderly: prevention and treatment
Clin Geriatr Med 18 (2002) 529 555 Osteoporosis in elderly: prevention and treatment Manish Srivastava, MD a, Chad Deal, MD b, * a Section of Geriatric Medicine, A91 Cleveland Clinic Foundation, 9500 Euclid
More informationCAPTURE THE FRACTURE A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE. www.iofbonehealth.org
CAPTURE THE FRACTURE A GLOBAL CAMPAIGN TO BREAK THE FRAGILITY FRACTURE CYCLE www.iofbonehealth.org normal bone osteoporotic bone WHAT IS OSTEOPOROSIS? Osteoporosis is a disease characterized by low bone
More informationTestosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS
Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS The faces of Low Testosterone What your patients are seeing Pharmacy Industry Testosterone
More informationHealthy Aging Lab: Current Research Abstracts
Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic
More informationMedications for Prevention and Treatment of Osteoporosis
1 Medications for Prevention and Treatment of Osteoporosis Osteoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal
More informationBone Densitometry and the Treatment of Osteoporosis
Reference Section Bone Densitometry and the Treatment of steoporosis a report by Dr Glen Blake and Professor Ignac Fogelman Senior Lecturer, and Professor of Nuclear Medicine, Guy s, King s and St Thomas
More informationHow To Take A Bone Marrow Transplant
Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates
More informationPCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES
PCHC FACTS ABOUT HEALTH CONDITIONS AND MOOD DIFFICULTIES Why should mood difficulties in individuals with a health condition be addressed? Many people with health conditions also experience mood difficulties
More informationScans and tests and osteoporosis
Scans and tests and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500. Hormone Therapy
Hormone Therapy WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 At menopause, a woman's body makes less estrogen and she stops having menstrual periods. This is a natural stage in a woman's
More informationSam Berman Dr. Kim Ferguson Samantha Dalby NP
Sam Berman Dr. Kim Ferguson Samantha Dalby NP CE LHIN Total population = 1,463,801 Estimated Family Physician shortage of 55 110 Unattached patient estimate of 86,000 Purpose was to provide unattached
More informationOsteoporosis International. Original Article. Calcium Supplement and Bone Medication Use in a US Medicare Health Maintenance Organization
Osteoporos Int (2002) 13:657 662 ß 2002 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Calcium Supplement and Bone Medication Use
More informationOsteoporosis is a common and costly systemic disease
OUTCOMES IN PRACTICE Osteoporosis Disease Management: Best Practices from the Penn State Geisinger Health System Eric D. Newman, MD, Ralph H. Starkey, MD, William T. Ayoub, MD, FACP, FACR, Charles M. Davis
More informationMedications to Prevent and Treat Osteoporosis
Medications to Prevent and Treat Osteoporosis National Institutes of Health Osteoporosis and Related Bone Diseases ~ National Resource Center 2 AMS Circle Bethesda, MD 20892-3676 Tel: (800) 624-BONE or
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationDrug treatments for osteoporosis
Drug treatments for osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,
More informationScreening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement
Screening Mammography for Breast Cancer: American College of Preventive Medicine Practice Policy Statement Rebecca Ferrini, MD, Elizabeth Mannino, MD, Edith Ramsdell, MD and Linda Hill, MD, MPH Burden
More informationQCT BMD Imaging vs DEXA BMD Imaging
QCT BMD Imaging vs DEXA BMD Imaging by Charles (Chuck) Maack Prostate Cancer Advocate Wichita, Kansas Chapter, Us TOO Intl., Inc. Dual-Energy X-ray Absorptiometry (DEXA) or Quantitative Computerized Tomography
More informationBone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring
Bone Markers in Osteoporosis: Prediction of Fractures & Treatment Monitoring Richard Eastell, MD FRCP FRCPath FMedSci, Professor of Bone Metabolism, University of Sheffield, Sheffield, UK Usefulness of
More informationMargaret French, Specialist Nurse, Fracture Liaison Service Glasgow Royal Infirmary Rachel Lewis Rheumatology Specialist Physiotherapist, North
Margaret French, Specialist Nurse, Fracture Liaison Service Glasgow Royal Infirmary Rachel Lewis Rheumatology Specialist Physiotherapist, North Bristol NHS Trust Very informal workshop to facilitate discussion
More informationLow-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital
Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the
More informationOsteoporotic fracture risk assessment
steoporotic fracture risk assessment de 24 29/08/2011 13:50 Official reprint from UpToDate www.uptodate.com 2011 UpToDate Osteoporotic fracture risk assessment Author E Michael Lewiecki, MD Disclosures
More informationRequests. Who requests a DXA scan? DXA. DXA Technology. Adequate Clinical Information
Requests Define a protocol for validation and prioritisation of densitometry requests. Registered medical practitioners In writing Include adequate clinical information Unsuitable requests should be discussed
More information